Back to Search
CHRISTOPHER KOO, M.D.
M.D.
Surgery Physician
NPI: 1891051934IndividualAccepts Medicare
Specialties, Licenses & Credentials
Transplant Surgery Physician
Transplant Surgery
Code: 204F00000X
MD467613(PA)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
MD467613(PA)04-49824(KS)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
PMID 19444461·Arch Gynecol Obstet·2010
8-other
The controlled formation and cleavage of an intramolecular d8-d8 Pt-Pt interaction in a dinuclear cycloplatinated molecular "pivot-hinge".
PMID 19562782·Chemistry·2009
8-other
Intraspinal hematoma following neuraxial anesthesia and low-molecular-weight heparin in two patients: risks and benefits of anticoagulation.
PMID 19627924·PM R·2009
5-case
A bioaccumulative cyclometalated platinum(II) complex with two-photon-induced emission for live cell imaging.
PMID 19128152·Inorg Chem·2009
7-preclinical
Manifestation of spin selection rules on the quantum tunneling of magnetization in a single-molecule magnet.
PMID 19659173·Phys Rev Lett·2009
8-other
Spin coating nanopatterned multielemental materials via self-assembled nanotemplates.
PMID 19433872·Nanotechnology·2009
8-other
Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
PMID 19476621·J Transl Med·2009
8-other
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.
PMID 19366452·J Transl Med·2009
8-other
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
PMID 19126645·Carcinogenesis·2009
8-other
Manufacturing by-products from, and stereochemical outcomes of the biotransformation of benzaldehyde used in the synthesis of methamphetamine.
PMID 19443151·Forensic Sci Int·2009
8-other
Single-molecule-magnet behavior and spin changes affected by crystal packing effects.
PMID 18771258·Inorg Chem·2008
8-other
Synthesis, magnetism, and high-frequency EPR spectroscopy of a family of mixed-valent cuboctahedral Mn13 complexes with 1,8-naphthalenedicarboxylate ligands.
PMID 18950241·Inorg Chem·2008
8-other
Cost-effectiveness and patient tolerance of low-attenuation oral contrast material: milk versus VoLumen.
PMID 18430848·AJR Am J Roentgenol·2008
4-observational
Heterometallic integer-spin analogues of S = 9/2 Mn4 cubane single-molecule magnets.
PMID 18327894·Inorg Chem·2008
8-other
Targeting heparan sulfate proteoglycans in breast cancer treatment.
PMID 18991783·Recent Pat Anticancer Drug Discov·2008
6-review
Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
PMID 17919839·Int J Radiat Oncol Biol Phys·2008
4-observational
Synthesis and spectroscopic studies of cyclometalated Pt(II) complexes containing a functionalized cyclometalating ligand, 2-phenyl-6-(1H-pyrazol-3-yl)-pyridine.
PMID 17408265·Inorg Chem·2007
8-other
Comparison of the effects of differentially sulphated bovine kidney- and porcine intestine-derived heparan sulphate on breast carcinoma cellular behaviour.
PMID 17982668·Int J Oncol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10550 QUIVIRA RD STE 250
OVERLAND PARK, KS 66215 - Phone
- (913) 541-3540
Quick Facts
- NPI
- 1891051934
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile